What does PHARMACIE DE CELLES do?

PHARMACIE DE CELLES is a pharmacy in Celles (lez-Tournai). Private Limited, started on 26 June 2008, 1 establishment.

What is the address of PHARMACIE DE CELLES?

The registered office of PHARMACIE DE CELLES is located at Rue Provinciale (C) 70, 7760 Celles (lez-Tournai).

Is PHARMACIE DE CELLES still active?

Yes. According to the CBE (2 November 2026) PHARMACIE DE CELLES is active, legal situation “Normale toestand”, started on 26 June 2008.

Is PHARMACIE DE CELLES registered on Peppol?

Yes, PHARMACIE DE CELLES is registered on the Peppol network with ID 0208:0898809918.

What is the enterprise number of PHARMACIE DE CELLES?

The enterprise number of PHARMACIE DE CELLES is BE0898809918.

When was PHARMACIE DE CELLES founded?

PHARMACIE DE CELLES was founded on 26 June 2008.

Who are the directors of PHARMACIE DE CELLES?

According to the 2025 annual accounts, the directors of PHARMACIE DE CELLES are: Fortimmo SA, Charles Voisin.

Is PHARMACIE DE CELLES a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 26 June 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMACIE DE CELLES make in 2025?

PHARMACIE DE CELLES posted a profit after taxes of € 114,090 in financial year 2025.

What is the revenue of PHARMACIE DE CELLES?

As a small company, PHARMACIE DE CELLES is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 255,091.

How much does an employee at PHARMACIE DE CELLES earn?

The average wage cost per full-time employee at PHARMACIE DE CELLES was € 57,200 in 2025: staff costs of € 114,424 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does PHARMACIE DE CELLES have?

According to the 2025 annual accounts, PHARMACIE DE CELLES has 2 full-time equivalents (FTE).

PHARMACIE DE CELLES (Private Limited)

Dossier PHARMACIE DE CELLES, printed on 2 November 2026 from databakkes.be/en/0898809918/pharmacie-de-celles. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 50 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

PHARMACIE DE CELLES from Celles (lez-Tournai), company number BE0898809918, closed financial year 2025 with a result of € 114,090 after tax. For that financial year PHARMACIE DE CELLES recorded a gross margin of € 255,091 and equity of € 167,057. Compared with financial year 2024, the result moved from € 169,388 to € 114,090. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 29, 2026.

What it is worth Growing

€ 167,057

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 114,090

▼ 33% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 84,289

▼ 14% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 110,000 paid out

96 % of the profit went to the shareholders, mostly to FORTIMMO (80 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

▲ 1 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 114,424

▲ 168% vs 2024

€ 57,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 40,053

▲ 12% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 538

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 32,119

▲ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 50,011

▲ 31% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 302,161 Gross margin 2022: € 302,161 First fiscal year in the series	€ 334,672 Gross margin 2023: € 334,672 ▲ 11% vs 2022 (€ 302,161) Favourable step	€ 214,577 Gross margin 2024: € 214,577 ▼ 36% vs 2023 (€ 334,672) Unfavourable step	€ 255,091 Gross margin 2025: € 255,091 ▲ 19% vs 2024 (€ 214,577) Favourable step	▲ 19%
Profit after taxes	€ 260,774 Profit after taxes 2022: € 260,774 First fiscal year in the series	€ 291,581 Profit after taxes 2023: € 291,581 ▲ 12% vs 2022 (€ 260,774) Favourable step	€ 169,388 Profit after taxes 2024: € 169,388 ▼ 42% vs 2023 (€ 291,581) Unfavourable step	€ 114,090 Profit after taxes 2025: € 114,090 ▼ 33% vs 2024 (€ 169,388) Unfavourable step	▼ 33%
Equity	€ 158,998 Equity 2022: € 158,998 First fiscal year in the series	€ 160,579 Equity 2023: € 160,579 ▲ 1% vs 2022 (€ 158,998) Favourable step	€ 162,967 Equity 2024: € 162,967 ▲ 1% vs 2023 (€ 160,579) Favourable step	€ 167,057 Equity 2025: € 167,057 ▲ 3% vs 2024 (€ 162,967) Favourable step	▲ 3%
Total debts	€ 293,043 Total debts 2022: € 293,043 First fiscal year in the series	€ 316,974 Total debts 2023: € 316,974 ▲ 8% vs 2022 (€ 293,043) Unfavourable step	€ 235,858 Total debts 2024: € 235,858 ▼ 26% vs 2023 (€ 316,974) Favourable step	€ 352,008 Total debts 2025: € 352,008 ▲ 49% vs 2024 (€ 235,858) Unfavourable step	▲ 49%
Cash	€ 217,557 Cash 2022: € 217,557 First fiscal year in the series	€ 193,122 Cash 2023: € 193,122 ▼ 11% vs 2022 (€ 217,557) Unfavourable step	€ 97,504 Cash 2024: € 97,504 ▼ 50% vs 2023 (€ 193,122) Unfavourable step	€ 84,289 Cash 2025: € 84,289 ▼ 14% vs 2024 (€ 97,504) Unfavourable step	▼ 14%
Retained profit	€ 33,998 Retained profit 2022: € 33,998 First fiscal year in the series	€ 35,579 Retained profit 2023: € 35,579 ▲ 5% vs 2022 (€ 33,998) Favourable step	€ 37,967 Retained profit 2024: € 37,967 ▲ 7% vs 2023 (€ 35,579) Favourable step	€ 42,057 Retained profit 2025: € 42,057 ▲ 11% vs 2024 (€ 37,967) Favourable step	▲ 11%
Dividend	€ 260,000 Dividend 2022: € 260,000 First fiscal year in the series	€ 290,000 Dividend 2023: € 290,000 ▲ 12% vs 2022 (€ 260,000) Unchanged	€ 167,000 Dividend 2024: € 167,000 ▼ 42% vs 2023 (€ 290,000) Unchanged	€ 110,000 Dividend 2025: € 110,000 ▼ 34% vs 2024 (€ 167,000) Unchanged	▼ 34%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 538 Bank debt 2025: € 538 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 452,041 Balance sheet total 2022: € 452,041 First fiscal year in the series	€ 477,553 Balance sheet total 2023: € 477,553 ▲ 6% vs 2022 (€ 452,041) Unchanged	€ 398,826 Balance sheet total 2024: € 398,826 ▼ 16% vs 2023 (€ 477,553) Unchanged	€ 519,066 Balance sheet total 2025: € 519,066 ▲ 30% vs 2024 (€ 398,826) Unchanged	▲ 30%
Employees (FTE)	1 Employees (FTE) 2022: 1 First fiscal year in the series	1 Employees (FTE) 2023: 1 Unchanged (1) Unchanged	1 Employees (FTE) 2024: 1 Unchanged (1) Unchanged	2 Employees (FTE) 2025: 2 ▲ 1 vs 2024 (1) Unchanged	▲ 1

Key figures of PHARMACIE DE CELLES, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMACIE DE CELLES?

What happened at PHARMACIE DE CELLES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 29, 2026 New annual accounts for financial year 2025: profit of € 114,090 (▼ 33% vs 2024). filed late Source: NBB ↗
2024 Fortimmo SA became a director. NBB
2024 Charles Voisin became a director. NBB
Jul 8, 2008 New establishment in Celles (lez-Tournai). KBO
Jun 26, 2008 Start of the company according to the CBE. KBO

In short

From € 260,774 profit in 2022 to € 114,090 profit in 2025.

Paid € 3,677 in corporate taxes since 2022.

Best year ever: 2023, with € 291,581 profit.

On average € 127,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

FORTIMMO 80%

The stake of FORTIMMO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

PHARMACIE DE CELLES

Behind PHARMACIE DE CELLES are Fortimmo SA and Charles Voisin. The shares are held by FORTIMMO (80%).

Directors

According to the 2025 annual accounts

Fortimmo SA

Director · represented by Ludovic Hernould

since 2024

Charles Voisin

Director

since 2024

Shareholders

FORTIMMO

80%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Provinciale (C) 70

7760 Celles (lez-Tournai)

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

VOISIN72 UNIT

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0898.809.918
VAT number: BE 0898.809.918
Registered office: Rue Provinciale (C) 70, 7760 Celles (lez-Tournai)
Names & denominations: PHARMACIE DE CELLES
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 26 June 2008
Peppol: Active · Active since 20 Nov 2020
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗